MyAverix Finance
US · Healthcare
Crescent Biopharma, Inc. (CBIO)
Biotechnology
Crescent Biopharma, Inc. (CBIO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CBIO
Crescent Biopharma, Inc. (CBIO) — FAQ
What is CBIO's P/E ratio?
The price-to-earnings (P/E) ratio for Crescent Biopharma, Inc. (CBIO) is 18.00 (data as of 2026-03-23).
Does Crescent Biopharma, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Crescent Biopharma, Inc. (CBIO). Check the MyAverix Finance app for the latest dividend data.
What sector is Crescent Biopharma, Inc. in?
Crescent Biopharma, Inc. (CBIO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CBIO listed on?
CBIO is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.